U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07310797) titled 'Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion' on Dec. 16.
Brief Summary: This randomized controlled trial compares the efficacy and safety of four treatment strategies for ureteral stone expulsion: Mirabegron alone, Tamsulosin alone, a combination of both, and standard conservative care. Participants diagnosed with ureteral stones will be randomly assigned to one of these four groups. The primary objective is to evaluate the stone expulsion rate within 4 weeks. The study also assesses time to expulsion, pain intensity, analgesic use, and potential side effects.
Study Start Date: Jan. 01, 2026
Study Type: IN...